Tonix Pharmaceuticals Sees TONMYA Revenue Growth and Sales Force Expansion
TNXP Tonix Pharmaceuticals Holding Corp
$4.49 -5.27%
View chart & analysis → - 1Tonix Pharmaceuticals recorded approximately $15 million in TONMYA net sales for the third quarter.
- 2Tonix Pharmaceuticals achieved a 28% growth rate in TONMYA prescriptions during the third quarter.
- 3The company completed plans to expand its sales force to 150 members.
So what's the key point?
Tonix Pharmaceuticals recorded $15 million in TONMYA sales. Prescriptions increased by 28% and the sales force was expanded to 150 members.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.